Group net sales grow by 6.3%* to EUR 14.0 billion, driven by Human Pharma (EUR 11.3 billion) and Animal Health (EUR 2.6 billion)Regulatory submissions underway for zongertinib and nerandomilast, with launches expected in…Read More

You might also be interested in reading XRP Price Correction Is Far From Over: Bearish Divergence Signals Potential Revisit To $2.05.